Transformed tobacco fields could cuts costs for medical proteins

tobacco plant
Credit: CC0 Public Domain

A new Cornell University-led study describes the first successful rearing of engineered tobacco plants in order to produce medical and industrial proteins outdoors in the field, a necessity for economic viability, so they can be grown at large scales.

The market for such biologically derived proteins is forecast to reach $300 billion in the near future. Industrial enzymes and other proteins are currently made in large, expensive fermenting reactors, but making them in plants grown outdoors could reduce by three times.

Researchers from Cornell and University of Illinois have engineered plants capable of making proteins not native to the plant itself. "We knew these plants grew well in the greenhouse, but we just never had the opportunity to test them out in the field," said Beth Ahner, professor of biological and and senior author of "Field-grown maintain robust growth while accumulating large quantities of a bacterial cellulase in chloroplasts," published in the journal Nature Plants.

That opportunity came when University of Illinois plant biology professor Stephen Long obtained a permit from the U.S. Department of Agriculture to grow the genetically modified plants in the field.

Conventional wisdom suggested that the burden of asking plants to turn 20 percent of the proteins they have in their cells into something the plant can't use would greatly stunt growth.

'If we're not using that cropland to make cigarettes anymore, then perhaps we could use that cropland to make enzymes.' Beth Ahner, professor of biological and environmental engineering at Cornell's College of Agriculture and Life Sciences, shows how tobacco plants can be used to make functional proteins for the manufacture of products such as denim, laundry detergent, paper and ethanol. Credit: John Munson, Cornell University

"When you put in the field, they have to face large transitions, in terms of drought or temperature or light, and they're going to need all the that they have," Ahner said. "But we show that the plant still is able to function perfectly normally in the field [while producing nonnative proteins]. That was really the breakthrough."

Jennifer Schmidt, a graduate student in Ahner's lab, and Justin McGrath, a research scientist in Long's lab, are co-first authors of the paper. Maureen Hanson, the Liberty Hyde Bailey Professor in the Department of Molecular Biology and Genetics, is also a co-author.


Explore further

New rhomboid-like protein helps plants produce lipids

More information: Field-grown tobacco plants maintain robust growth while accumulating large quantities of a bacterial cellulase in chloroplasts, Nature Plants (2019). DOI: 10.1038/s41477-019-0467-z , https://nature.com/articles/s41477-019-0467-z
Journal information: Nature Plants

Provided by Cornell University
Citation: Transformed tobacco fields could cuts costs for medical proteins (2019, July 8) retrieved 15 September 2019 from https://phys.org/news/2019-07-tobacco-fields-medical-proteins.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
92 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more